Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
Redmile Group LLC | 2,246,668 6.100% |
-439,566 (-16.36%) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Yumanity Therapeutics, Inc. YMTX |
Redmile Group LLC | 8,935 0.600% |
-87,286 (-90.71%) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Redmile Group LLC | 0 0.000% |
-2,416,406 (Position Closed) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Allakos Inc. ALLK |
Redmile Group LLC | 2,077,875 3.800% |
-589,576 (-22.10%) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Redmile Group LLC | 363,949 9.900% |
49,404 (+15.71%) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Atreca, Inc. BCEL |
Redmile Group LLC | 800,306 2.600% |
-1,675,762 (-67.68%) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | GRITSTONE BIO INC GRTSQ |
Redmile Group LLC | 7,265,514 9.900% |
1,535,598 (+26.80%) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Redmile Group LLC | 2,165,586 4.600% |
-546,030 (-20.14%) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Redmile Group LLC | 2,958,284 6.600% |
112,159 (+3.94%) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Repare Therapeutics Inc. RPTX |
Redmile Group LLC | 2,789,496 6.700% |
141,800 (+5.36%) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | TCR2 Therapeutics Inc. TCRR |
Redmile Group LLC | 1,346,058 3.500% |
-1,486,830 (-52.48%) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Dynamics Special Purpose Corp. DYNS |
Redmile Group LLC | 0 0.000% |
-2,012,900 (Position Closed) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Entrada Therapeutics, Inc. TRDA |
Redmile Group LLC | 1,954,420 6.300% |
1,954,420 (New Position) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Kymera Therapeutics, Inc. KYMR |
Redmile Group LLC | 2,587,730 5.000% |
-132,759 (-4.88%) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Redmile Group LLC | 3,083,501 8.600% |
-304,875 (-9.00%) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | REGENXBIO Inc. RGNX |
Redmile Group LLC | 1,897,223 4.400% |
-226,269 (-10.66%) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Beam Therapeutics Inc. BEAM |
Redmile Group LLC | 1,885,850 2.800% |
-1,892,412 (-50.09%) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Achilles Therapeutics plc ACHL |
Redmile Group LLC | 2,088,089 5.100% |
2,088,089 (New Position) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | ADC Therapeutics SA ADCT |
Redmile Group LLC | 7,451,029 9.700% |
692,235 (+10.24%) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Annexon, Inc. ANNX |
Redmile Group LLC | 3,228,917 8.400% |
-219,113 (-6.35%) |
Filing History |